img

Global Aurora Kinase A Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Aurora Kinase A Antibody Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Aurora Kinase A Antibody is a specific antibody for detection and research of Aurora Kinase A protein (Aurora Kinase A).
Aurora Kinase A Antibody report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Aurora Kinase A Antibody market is projected to reach US$ 894.4 million in 2029, increasing from US$ 394.6 million in 2022, with the CAGR of 12.4% during the period of 2024 to 2029. Demand from Flow Cytometry and ELISA are the major drivers for the industry.
Aurora kinase A is a mitogen-activated protein kinase that participates in regulating important biological processes such as cell mitosis and chromosome segregation. Its expression and activity changes at different stages of the cell cycle, especially during the G2/M period of cell division. Abnormal expression or increased activity of Aurora kinase A is associated with the occurrence and development of various tumors. Aurora kinase A antibodies can be used to study the expression and activation mechanism of Aurora kinase A, as well as its relationship with cell cycle regulation, tumor biology, etc., and help to gain a deeper understanding of the function of Aurora kinase A in normal cell physiology and disease mechanisms. In addition, due to its role in tumors, Aurora kinase A antibodies may also have potential applications in cancer diagnosis, treatment, and prognosis
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Aurora Kinase A Antibody market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


RayBiotech, Inc.
MyBiosource, Inc.
Bio-Techne
Arigo Biolaboratories Corp.
Abcam
Abbexa
GeneTex
Biorbyt
OriGene Technologies, Inc.
LifeSpan BioSciences, Inc
Assay Genie
Creative Biolabs
Segment by Type
Monoclonal Antibody
Polyclonal Antibody

Segment by Application


Flow Cytometry
ELISA
Western Blot
Immunoprecipitation
Immunofluorescence
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Aurora Kinase A Antibody market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Aurora Kinase A Antibody, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Aurora Kinase A Antibody industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Aurora Kinase A Antibody in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Aurora Kinase A Antibody introduction, etc. Aurora Kinase A Antibody Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Aurora Kinase A Antibody market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Aurora Kinase A Antibody Market Overview
1.1 Aurora Kinase A Antibody Product Overview
1.2 Aurora Kinase A Antibody Market Segment by Type
1.2.1 Monoclonal Antibody
1.2.2 Polyclonal Antibody
1.3 Global Aurora Kinase A Antibody Market Size by Type
1.3.1 Global Aurora Kinase A Antibody Market Size Overview by Type (2018-2029)
1.3.2 Global Aurora Kinase A Antibody Historic Market Size Review by Type (2018-2024)
1.3.3 Global Aurora Kinase A Antibody Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Aurora Kinase A Antibody Sales Breakdown by Type (2018-2024)
1.4.2 Europe Aurora Kinase A Antibody Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Aurora Kinase A Antibody Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Aurora Kinase A Antibody Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Aurora Kinase A Antibody Sales Breakdown by Type (2018-2024)
2 Global Aurora Kinase A Antibody Market Competition by Company
2.1 Global Top Players by Aurora Kinase A Antibody Sales (2018-2024)
2.2 Global Top Players by Aurora Kinase A Antibody Revenue (2018-2024)
2.3 Global Top Players by Aurora Kinase A Antibody Price (2018-2024)
2.4 Global Top Manufacturers Aurora Kinase A Antibody Manufacturing Base Distribution, Sales Area, Product Type
2.5 Aurora Kinase A Antibody Market Competitive Situation and Trends
2.5.1 Aurora Kinase A Antibody Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Aurora Kinase A Antibody Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase A Antibody as of 2022)
2.7 Date of Key Manufacturers Enter into Aurora Kinase A Antibody Market
2.8 Key Manufacturers Aurora Kinase A Antibody Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Aurora Kinase A Antibody Status and Outlook by Region
3.1 Global Aurora Kinase A Antibody Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Aurora Kinase A Antibody Historic Market Size by Region
3.2.1 Global Aurora Kinase A Antibody Sales in Volume by Region (2018-2024)
3.2.2 Global Aurora Kinase A Antibody Sales in Value by Region (2018-2024)
3.2.3 Global Aurora Kinase A Antibody Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Aurora Kinase A Antibody Forecasted Market Size by Region
3.3.1 Global Aurora Kinase A Antibody Sales in Volume by Region (2024-2029)
3.3.2 Global Aurora Kinase A Antibody Sales in Value by Region (2024-2029)
3.3.3 Global Aurora Kinase A Antibody Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Aurora Kinase A Antibody by Application
4.1 Aurora Kinase A Antibody Market Segment by Application
4.1.1 Flow Cytometry
4.1.2 ELISA
4.1.3 Western Blot
4.1.4 Immunoprecipitation
4.1.5 Immunofluorescence
4.1.6 Others
4.2 Global Aurora Kinase A Antibody Market Size by Application
4.2.1 Global Aurora Kinase A Antibody Market Size Overview by Application (2018-2029)
4.2.2 Global Aurora Kinase A Antibody Historic Market Size Review by Application (2018-2024)
4.2.3 Global Aurora Kinase A Antibody Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Aurora Kinase A Antibody Sales Breakdown by Application (2018-2024)
4.3.2 Europe Aurora Kinase A Antibody Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Aurora Kinase A Antibody Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Aurora Kinase A Antibody Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Aurora Kinase A Antibody Sales Breakdown by Application (2018-2024)
5 North America Aurora Kinase A Antibody by Country
5.1 North America Aurora Kinase A Antibody Historic Market Size by Country
5.1.1 North America Aurora Kinase A Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Aurora Kinase A Antibody Sales in Volume by Country (2018-2024)
5.1.3 North America Aurora Kinase A Antibody Sales in Value by Country (2018-2024)
5.2 North America Aurora Kinase A Antibody Forecasted Market Size by Country
5.2.1 North America Aurora Kinase A Antibody Sales in Volume by Country (2024-2029)
5.2.2 North America Aurora Kinase A Antibody Sales in Value by Country (2024-2029)
6 Europe Aurora Kinase A Antibody by Country
6.1 Europe Aurora Kinase A Antibody Historic Market Size by Country
6.1.1 Europe Aurora Kinase A Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Aurora Kinase A Antibody Sales in Volume by Country (2018-2024)
6.1.3 Europe Aurora Kinase A Antibody Sales in Value by Country (2018-2024)
6.2 Europe Aurora Kinase A Antibody Forecasted Market Size by Country
6.2.1 Europe Aurora Kinase A Antibody Sales in Volume by Country (2024-2029)
6.2.2 Europe Aurora Kinase A Antibody Sales in Value by Country (2024-2029)
7 Asia-Pacific Aurora Kinase A Antibody by Region
7.1 Asia-Pacific Aurora Kinase A Antibody Historic Market Size by Region
7.1.1 Asia-Pacific Aurora Kinase A Antibody Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Aurora Kinase A Antibody Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Aurora Kinase A Antibody Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Aurora Kinase A Antibody Forecasted Market Size by Region
7.2.1 Asia-Pacific Aurora Kinase A Antibody Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Aurora Kinase A Antibody Sales in Value by Region (2024-2029)
8 Latin America Aurora Kinase A Antibody by Country
8.1 Latin America Aurora Kinase A Antibody Historic Market Size by Country
8.1.1 Latin America Aurora Kinase A Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Aurora Kinase A Antibody Sales in Volume by Country (2018-2024)
8.1.3 Latin America Aurora Kinase A Antibody Sales in Value by Country (2018-2024)
8.2 Latin America Aurora Kinase A Antibody Forecasted Market Size by Country
8.2.1 Latin America Aurora Kinase A Antibody Sales in Volume by Country (2024-2029)
8.2.2 Latin America Aurora Kinase A Antibody Sales in Value by Country (2024-2029)
9 Middle East and Africa Aurora Kinase A Antibody by Country
9.1 Middle East and Africa Aurora Kinase A Antibody Historic Market Size by Country
9.1.1 Middle East and Africa Aurora Kinase A Antibody Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Aurora Kinase A Antibody Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Aurora Kinase A Antibody Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Aurora Kinase A Antibody Forecasted Market Size by Country
9.2.1 Middle East and Africa Aurora Kinase A Antibody Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Aurora Kinase A Antibody Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 RayBiotech, Inc.
10.1.1 RayBiotech, Inc. Company Information
10.1.2 RayBiotech, Inc. Introduction and Business Overview
10.1.3 RayBiotech, Inc. Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.1.4 RayBiotech, Inc. Aurora Kinase A Antibody Products Offered
10.1.5 RayBiotech, Inc. Recent Development
10.2 MyBiosource, Inc.
10.2.1 MyBiosource, Inc. Company Information
10.2.2 MyBiosource, Inc. Introduction and Business Overview
10.2.3 MyBiosource, Inc. Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.2.4 MyBiosource, Inc. Aurora Kinase A Antibody Products Offered
10.2.5 MyBiosource, Inc. Recent Development
10.3 Bio-Techne
10.3.1 Bio-Techne Company Information
10.3.2 Bio-Techne Introduction and Business Overview
10.3.3 Bio-Techne Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Bio-Techne Aurora Kinase A Antibody Products Offered
10.3.5 Bio-Techne Recent Development
10.4 Arigo Biolaboratories Corp.
10.4.1 Arigo Biolaboratories Corp. Company Information
10.4.2 Arigo Biolaboratories Corp. Introduction and Business Overview
10.4.3 Arigo Biolaboratories Corp. Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Arigo Biolaboratories Corp. Aurora Kinase A Antibody Products Offered
10.4.5 Arigo Biolaboratories Corp. Recent Development
10.5 Abcam
10.5.1 Abcam Company Information
10.5.2 Abcam Introduction and Business Overview
10.5.3 Abcam Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Abcam Aurora Kinase A Antibody Products Offered
10.5.5 Abcam Recent Development
10.6 Abbexa
10.6.1 Abbexa Company Information
10.6.2 Abbexa Introduction and Business Overview
10.6.3 Abbexa Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Abbexa Aurora Kinase A Antibody Products Offered
10.6.5 Abbexa Recent Development
10.7 GeneTex
10.7.1 GeneTex Company Information
10.7.2 GeneTex Introduction and Business Overview
10.7.3 GeneTex Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.7.4 GeneTex Aurora Kinase A Antibody Products Offered
10.7.5 GeneTex Recent Development
10.8 Biorbyt
10.8.1 Biorbyt Company Information
10.8.2 Biorbyt Introduction and Business Overview
10.8.3 Biorbyt Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Biorbyt Aurora Kinase A Antibody Products Offered
10.8.5 Biorbyt Recent Development
10.9 OriGene Technologies, Inc.
10.9.1 OriGene Technologies, Inc. Company Information
10.9.2 OriGene Technologies, Inc. Introduction and Business Overview
10.9.3 OriGene Technologies, Inc. Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.9.4 OriGene Technologies, Inc. Aurora Kinase A Antibody Products Offered
10.9.5 OriGene Technologies, Inc. Recent Development
10.10 LifeSpan BioSciences, Inc
10.10.1 LifeSpan BioSciences, Inc Company Information
10.10.2 LifeSpan BioSciences, Inc Introduction and Business Overview
10.10.3 LifeSpan BioSciences, Inc Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.10.4 LifeSpan BioSciences, Inc Aurora Kinase A Antibody Products Offered
10.10.5 LifeSpan BioSciences, Inc Recent Development
10.11 Assay Genie
10.11.1 Assay Genie Company Information
10.11.2 Assay Genie Introduction and Business Overview
10.11.3 Assay Genie Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Assay Genie Aurora Kinase A Antibody Products Offered
10.11.5 Assay Genie Recent Development
10.12 Creative Biolabs
10.12.1 Creative Biolabs Company Information
10.12.2 Creative Biolabs Introduction and Business Overview
10.12.3 Creative Biolabs Aurora Kinase A Antibody Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Creative Biolabs Aurora Kinase A Antibody Products Offered
10.12.5 Creative Biolabs Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Aurora Kinase A Antibody Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Aurora Kinase A Antibody Industrial Chain Analysis
11.4 Aurora Kinase A Antibody Market Dynamics
11.4.1 Aurora Kinase A Antibody Industry Trends
11.4.2 Aurora Kinase A Antibody Market Drivers
11.4.3 Aurora Kinase A Antibody Market Challenges
11.4.4 Aurora Kinase A Antibody Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Aurora Kinase A Antibody Distributors
12.3 Aurora Kinase A Antibody Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Monoclonal Antibody
Table 2. Major Company of Polyclonal Antibody
Table 3. Global Aurora Kinase A Antibody Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Aurora Kinase A Antibody Sales by Type (2018-2024) & (K Units)
Table 5. Global Aurora Kinase A Antibody Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Aurora Kinase A Antibody Sales by Type (2018-2024) & (US& Million)
Table 7. Global Aurora Kinase A Antibody Market Share in Value by Type (2018-2024)
Table 8. Global Aurora Kinase A Antibody Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Aurora Kinase A Antibody Sales by Type (2024-2029) & (K Units)
Table 10. Global Aurora Kinase A Antibody Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Aurora Kinase A Antibody Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Aurora Kinase A Antibody Sales Market Share in Value by Type (2024-2029)
Table 13. Global Aurora Kinase A Antibody Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Aurora Kinase A Antibody Sales by Type (2018-2024) & (K Units)
Table 15. North America Aurora Kinase A Antibody Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Aurora Kinase A Antibody Sales (K Units) by Type (2018-2024)
Table 17. Europe Aurora Kinase A Antibody Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Aurora Kinase A Antibody Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Aurora Kinase A Antibody Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Aurora Kinase A Antibody Sales (K Units) by Type (2018-2024)
Table 21. Latin America Aurora Kinase A Antibody Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Aurora Kinase A Antibody Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Aurora Kinase A Antibody Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Aurora Kinase A Antibody Sales by Company (2018-2024) & (K Units)
Table 25. Global Aurora Kinase A Antibody Sales Share by Company (2018-2024)
Table 26. Global Aurora Kinase A Antibody Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Aurora Kinase A Antibody Revenue Share by Company (2018-2024)
Table 28. Global Market Aurora Kinase A Antibody Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Aurora Kinase A Antibody Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Aurora Kinase A Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Aurora Kinase A Antibody as of 2022)
Table 32. Date of Key Manufacturers Enter into Aurora Kinase A Antibody Market
Table 33. Key Manufacturers Aurora Kinase A Antibody Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Aurora Kinase A Antibody Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Aurora Kinase A Antibody Sales by Region (2018-2024) & (K Units)
Table 37. Global Aurora Kinase A Antibody Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Aurora Kinase A Antibody Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Aurora Kinase A Antibody Sales Market Share in Value by Region (2018-2024)
Table 40. Global Aurora Kinase A Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Aurora Kinase A Antibody Sales by Region (2024-2029) & (K Units)
Table 42. Global Aurora Kinase A Antibody Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Aurora Kinase A Antibody Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Aurora Kinase A Antibody Sales Market Share in Value by Region (2024-2029)
Table 45. Global Aurora Kinase A Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Aurora Kinase A Antibody Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Aurora Kinase A Antibody Sales by Application (2018-2024) & (K Units)
Table 48. Global Aurora Kinase A Antibody Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Aurora Kinase A Antibody Sales Market Share in Value by Application (2018-2024)
Table 51. Global Aurora Kinase A Antibody Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Aurora Kinase A Antibody Sales by Application (2024-2029) & (K Units)
Table 53. Global Aurora Kinase A Antibody Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Aurora Kinase A Antibody Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Aurora Kinase A Antibody Sales Market Share in Value by Application (2024-2029)
Table 56. Global Aurora Kinase A Antibody Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Aurora Kinase A Antibody Sales by Application (2018-2024) (K Units)
Table 58. North America Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Aurora Kinase A Antibody Sales by Application (2018-2024) (K Units)
Table 60. Europe Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Aurora Kinase A Antibody Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Aurora Kinase A Antibody Sales by Application (2018-2024) (K Units)
Table 64. Latin America Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Aurora Kinase A Antibody Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Aurora Kinase A Antibody Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Aurora Kinase A Antibody Sales by Country (2018-2024) & (K Units)
Table 68. North America Aurora Kinase A Antibody Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Aurora Kinase A Antibody Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Aurora Kinase A Antibody Sales Market Share in Value by Country (2018-2024)
Table 71. North America Aurora Kinase A Antibody Sales by Country (2024-2029) & (K Units)
Table 72. North America Aurora Kinase A Antibody Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Aurora Kinase A Antibody Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Aurora Kinase A Antibody Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Aurora Kinase A Antibody Sales by Country (2018-2024) & (K Units)
Table 76. Europe Aurora Kinase A Antibody Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Aurora Kinase A Antibody Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Aurora Kinase A Antibody Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Aurora Kinase A Antibody Sales by Country (2024-2029) & (K Units)
Table 80. Europe Aurora Kinase A Antibody Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Aurora Kinase A Antibody Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Aurora Kinase A Antibody Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Aurora Kinase A Antibody Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Aurora Kinase A Antibody Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Aurora Kinase A Antibody Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Aurora Kinase A Antibody Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Aurora Kinase A Antibody Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Aurora Kinase A Antibody Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Aurora Kinase A Antibody Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Aurora Kinase A Antibody Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Aurora Kinase A Antibody Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Aurora Kinase A Antibody Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Aurora Kinase A Antibody Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Aurora Kinase A Antibody Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Aurora Kinase A Antibody Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Aurora Kinase A Antibody Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Aurora Kinase A Antibody Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Aurora Kinase A Antibody Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Value by Country (2024-2029)
Table 107. RayBiotech, Inc. Company Information
Table 108. RayBiotech, Inc. Introduction and Business Overview
Table 109. RayBiotech, Inc. Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. RayBiotech, Inc. Aurora Kinase A Antibody Product
Table 111. RayBiotech, Inc. Recent Development
Table 112. MyBiosource, Inc. Company Information
Table 113. MyBiosource, Inc. Introduction and Business Overview
Table 114. MyBiosource, Inc. Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. MyBiosource, Inc. Aurora Kinase A Antibody Product
Table 116. MyBiosource, Inc. Recent Development
Table 117. Bio-Techne Company Information
Table 118. Bio-Techne Introduction and Business Overview
Table 119. Bio-Techne Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Bio-Techne Aurora Kinase A Antibody Product
Table 121. Bio-Techne Recent Development
Table 122. Arigo Biolaboratories Corp. Company Information
Table 123. Arigo Biolaboratories Corp. Introduction and Business Overview
Table 124. Arigo Biolaboratories Corp. Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Arigo Biolaboratories Corp. Aurora Kinase A Antibody Product
Table 126. Arigo Biolaboratories Corp. Recent Development
Table 127. Abcam Company Information
Table 128. Abcam Introduction and Business Overview
Table 129. Abcam Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Abcam Aurora Kinase A Antibody Product
Table 131. Abcam Recent Development
Table 132. Abbexa Company Information
Table 133. Abbexa Introduction and Business Overview
Table 134. Abbexa Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Abbexa Aurora Kinase A Antibody Product
Table 136. Abbexa Recent Development
Table 137. GeneTex Company Information
Table 138. GeneTex Introduction and Business Overview
Table 139. GeneTex Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. GeneTex Aurora Kinase A Antibody Product
Table 141. GeneTex Recent Development
Table 142. Biorbyt Company Information
Table 143. Biorbyt Introduction and Business Overview
Table 144. Biorbyt Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Biorbyt Aurora Kinase A Antibody Product
Table 146. Biorbyt Recent Development
Table 147. OriGene Technologies, Inc. Company Information
Table 148. OriGene Technologies, Inc. Introduction and Business Overview
Table 149. OriGene Technologies, Inc. Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. OriGene Technologies, Inc. Aurora Kinase A Antibody Product
Table 151. OriGene Technologies, Inc. Recent Development
Table 152. LifeSpan BioSciences, Inc Company Information
Table 153. LifeSpan BioSciences, Inc Introduction and Business Overview
Table 154. LifeSpan BioSciences, Inc Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. LifeSpan BioSciences, Inc Aurora Kinase A Antibody Product
Table 156. LifeSpan BioSciences, Inc Recent Development
Table 157. Assay Genie Company Information
Table 158. Assay Genie Introduction and Business Overview
Table 159. Assay Genie Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Assay Genie Aurora Kinase A Antibody Product
Table 161. Assay Genie Recent Development
Table 162. Creative Biolabs Company Information
Table 163. Creative Biolabs Introduction and Business Overview
Table 164. Creative Biolabs Aurora Kinase A Antibody Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Creative Biolabs Aurora Kinase A Antibody Product
Table 166. Creative Biolabs Recent Development
Table 167. Key Raw Materials Lists
Table 168. Raw Materials Key Suppliers Lists
Table 169. Aurora Kinase A Antibody Market Trends
Table 170. Aurora Kinase A Antibody Market Drivers
Table 171. Aurora Kinase A Antibody Market Challenges
Table 172. Aurora Kinase A Antibody Market Restraints
Table 173. Aurora Kinase A Antibody Distributors List
Table 174. Aurora Kinase A Antibody Downstream Customers
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Aurora Kinase A Antibody Product Picture
Figure 2. Global Aurora Kinase A Antibody Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Aurora Kinase A Antibody Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Aurora Kinase A Antibody Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Monoclonal Antibody
Figure 6. Global Monoclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Polyclonal Antibody
Figure 8. Global Polyclonal Antibody Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Aurora Kinase A Antibody Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Aurora Kinase A Antibody Sales Market Share by Type in 2022 & 2029
Figure 11. North America Aurora Kinase A Antibody Sales Market Share in Volume by Type in 2022
Figure 12. North America Aurora Kinase A Antibody Sales Market Share in Value by Type in 2022
Figure 13. Europe Aurora Kinase A Antibody Sales Market Share in Volume by Type in 2022
Figure 14. Europe Aurora Kinase A Antibody Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Value by Type in 2022
Figure 17. Latin America Aurora Kinase A Antibody Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Aurora Kinase A Antibody Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Aurora Kinase A Antibody Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Aurora Kinase A Antibody Revenue in 2022
Figure 23. Aurora Kinase A Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Flow Cytometry
Figure 25. Global Flow Cytometry Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of ELISA
Figure 27. Global ELISA Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Western Blot
Figure 29. Global Western Blot Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Immunoprecipitation
Figure 31. Global Immunoprecipitation Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Product Picture of Immunofluorescence
Figure 33. Global Immunofluorescence Sales YoY Growth (2018-2029) & (K Units)
Figure 34. Product Picture of Others
Figure 35. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 36. Global Aurora Kinase A Antibody Sales by Application (2018-2029) & (US$ Million)
Figure 37. Global Aurora Kinase A Antibody Sales Market Share by Application in 2022 & 2029
Figure 38. North America Aurora Kinase A Antibody Sales Market Share in Volume by Application in 2022
Figure 39. North America Aurora Kinase A Antibody Sales Market Share in Value by Application in 2022
Figure 40. Europe Aurora Kinase A Antibody Sales Market Share in Volume by Application in 2022
Figure 41. Europe Aurora Kinase A Antibody Sales Market Share in Value by Application in 2022
Figure 42. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Volume by Application in 2022
Figure 43. Asia-Pacific Aurora Kinase A Antibody Sales Market Share in Value by Application in 2022
Figure 44. Latin America Aurora Kinase A Antibody Sales Market Share in Volume by Application in 2022
Figure 45. Latin America Aurora Kinase A Antibody Sales Market Share in Value by Application in 2022
Figure 46. Middle East and Africa Aurora Kinase A Antibody Sales Market Share in Value by Application in 2022
Figure 47. Key Raw Materials Price
Figure 48. Aurora Kinase A Antibody Manufacturing Cost Structure
Figure 49. Aurora Kinase A Antibody Industrial Chain Analysis
Figure 50. Channels of Distribution
Figure 51. Distributors Profiles
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation
Figure 54. Key Executives Interviewed